Investigating traditional and modern approaches to antimicrobial susceptibility testing
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
This partnership aims to offer an accelerated route to market rapid test technologies
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase
Explore topics from immunoassays, immunotherapeutics and immuno-oncology to Raman spectroscopy, metabolomics, and COVID-19
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development
Through automation of manual tasks, Roche’s new solution is designed to simplify workflows and improve the productivity of lab personnel whilst also supporting the delivery of better patient care
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
Explore topics from immunoassays and immunotherapeutics to high-sensitivity troponin assays, metabolomics, and in situ hybridization
The monthly safety report will be made public on the European Medicines Agency website
UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows
Abbott will rapidly develop tests that can be used to help identify, isolate, and contain outbreaks when potential new virus threats are identified